These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 35987868)
21. Neoadjuvant chemotherapy in stage III NSCLC. Allen J; Jahanzeb M J Natl Compr Canc Netw; 2008 Mar; 6(3):285-93. PubMed ID: 18377847 [TBL] [Abstract][Full Text] [Related]
22. Comment on "Survival improvement in resectable non-small cell lung cancer with (neo)adjuvant chemotherapy: results of a meta-analysis of the literature" by T. Berghmans, M. Paesmans, A.P. Meert, C. Mascaux, P. Lothaire, J.J. Lafitte, et al. [Lung Cancer 49 (2005) 13-23.]. Pignon JP; Burdett S Lung Cancer; 2006 Feb; 51(2):261-2; author reply 263-5. PubMed ID: 16417944 [No Abstract] [Full Text] [Related]
24. [Controversy in the treatment of non-small cell lung cancer. Timing of chemotherapy in relation to surgery: before or after?]. Dediu M Pneumologia; 2004; 53(3):105-8. PubMed ID: 16108158 [No Abstract] [Full Text] [Related]
25. Multimodality therapy for non-small cell lung cancer (NSCLC): ongoing Italian experiences in the adjuvant and neoadjuvant settings. Crinò L; Cappuzzo F Lung Cancer; 2001 Dec; 34 Suppl 3():S45-7. PubMed ID: 11740993 [No Abstract] [Full Text] [Related]
26. Chemotherapy and immunotherapy in early-stage NSCLC: neoadjuvant vs adjuvant therapy. Wakelee H Clin Adv Hematol Oncol; 2023 Dec; 21(12):648-651. PubMed ID: 38039058 [No Abstract] [Full Text] [Related]
27. Neoadjuvant nivolumab with chemotherapy: A miraculous new regime in treatment of resectable lung cancers. Babar N; Hasan SZ; Rabbani S J Pak Med Assoc; 2023 Jan; 73(1):226. PubMed ID: 36842057 [No Abstract] [Full Text] [Related]
28. Does Neoadjuvant Chemotherapy Have a Role in Stage IIIA Lung Cancer Requiring Pneumonectomy? Baisi A; Raveglia F; De Simone M; Cioffi U Ann Thorac Surg; 2016 Sep; 102(3):1029. PubMed ID: 27549529 [No Abstract] [Full Text] [Related]
33. [Current status of the neo-adjuvant and adjuvant therapy for the resectable non-small cell lung cancer]. Yamaguchi M; Fukuyama Y; Ichinose Y Gan To Kagaku Ryoho; 2003 Feb; 30(2):203-8. PubMed ID: 12610867 [TBL] [Abstract][Full Text] [Related]
36. The new era of immune checkpoint inhibition and target therapy in early-stage non-small cell lung cancer. A review of the literature. Catania C; Muthusamy B; Spitaleri G; Del Signore E; Pennell NA Clin Lung Cancer; 2022 Mar; 23(2):108-115. PubMed ID: 34952792 [TBL] [Abstract][Full Text] [Related]
38. [The outcome and safety of neoadjuvant PD-1 blockade plus chemotherapy in stage Ⅱ~Ⅲ non-small cell lung cancer]. Liu YT; Gao YS; Mao YS; Jiang J; Yang L; Yang JL; Hu XS; Zhou SY; Qin Y; Shi YK Zhonghua Zhong Liu Za Zhi; 2020 Jun; 42(6):480-485. PubMed ID: 32575944 [No Abstract] [Full Text] [Related]
39. Chemotherapy and radiotherapy in the treatment of resectable non-small-cell lung cancer. Bernstein ED; Herbert SM; Hanna NH Ann Surg Oncol; 2006 Mar; 13(3):291-301. PubMed ID: 16450219 [TBL] [Abstract][Full Text] [Related]
40. What outcome after the prescription of neoadjuvant chemotherapy in lung cancer? Boudaya MS; Smadhi H; Marghli A; Charmiti F; Ouerghi S; Mohamed J; Brahem E; Smati B; Mestiri T; Kilani T Asian Cardiovasc Thorac Ann; 2013 Aug; 21(4):432-6. PubMed ID: 24570525 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]